GlassScriptPhysician profile
Danielle Marie Thomas
NPI 1801315171
$6,014.74
in general payments reported to CMS, 2019-2025
41 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,264 · 2022: $1,276 · 2023: $1,155 · 2024: $1,130 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,475.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,082.91 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $694.08 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Janssen Pharmaceuticals, INC | $473.73 | 2021-2025 | Spravato, Xarelto |
| Lilly USA, LLC | $437.88 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $351.43 | 2023-2025 | Xifaxan |
| Amgen INC. | $329.74 | 2022-2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $271.82 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $221.13 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbott Laboratories | $202.50 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Pfizer INC. | $172.23 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $150.48 | 2021-2025 | Gardasil 9, Capvaxive, Dificid |
| Biohaven Pharmaceuticals, INC. | $123.17 | 2021 | |
| Exact Sciences Corporation | $121.45 | 2023-2025 | Cologuard Collection Kit |
| Verity Pharmaceuticals INC. | $120.45 | 2024-2025 | Tlando |
| Amarin Pharma, INC. | $105.23 | 2021-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.